137 related articles for article (PubMed ID: 38672568)
1. Overall Survival after Radiotherapy for Brain Metastases According to ECOG Status-A Prospective Study of 294 NSCLC Patients.
Karlsson AT; Hjermstad MJ; Aass N; Skovlund E; Kaasa S; Yri OE
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672568
[TBL] [Abstract][Full Text] [Related]
2. Overall survival after initial radiotherapy for brain metastases; a population based study of 2140 patients with non-small cell lung cancer.
Karlsson AT; Hjermstad MJ; Omdahl T; Aass N; Skovlund E; Hellebust TP; Johansen S; Kaasa S; Yri OE
Acta Oncol; 2021 Aug; 60(8):1054-1060. PubMed ID: 34032536
[TBL] [Abstract][Full Text] [Related]
3. Effect of whole-brain radiotherapy with platinum-based chemotherapy in non-small cell lung cancer patients with multiple metastases including brain metastases.
Ryu WK; Cha HK; Kim W; Lee HY; Kim HJ; Ryu JS; Lim JH
Sci Rep; 2023 Aug; 13(1):13173. PubMed ID: 37580499
[TBL] [Abstract][Full Text] [Related]
4. Whole brain radiotherapy in management of non-small-cell lung carcinoma associated leptomeningeal carcinomatosis: evaluation of prognostic factors.
Ozdemir Y; Yildirim BA; Topkan E
J Neurooncol; 2016 Sep; 129(2):329-35. PubMed ID: 27306442
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in patients with non-small cell lung carcinoma and brain metastases: a Malaysian perspective.
Tang WH; Alip A; Saad M; Phua VC; Chandran H; Tan YH; Tan YY; Kua VF; Wahid MI; Tho LM
Asian Pac J Cancer Prev; 2015; 16(5):1901-6. PubMed ID: 25773842
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Anlotinib in Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Study.
Zhong Q; Liu Z
Cancer Manag Res; 2021; 13():4115-4128. PubMed ID: 34045898
[TBL] [Abstract][Full Text] [Related]
7. Poor performance status and brain metastases treatment: who may benefit from the stereotactic radiotherapy?
Holub K; Louvel G
J Neurooncol; 2021 Apr; 152(2):383-393. PubMed ID: 33590401
[TBL] [Abstract][Full Text] [Related]
8. Real-world analysis of different intracranial radiation therapies in non-small cell lung cancer patients with 1-4 brain metastases.
Chen Z; Zhou L; Zhao M; Cao K; Li Y; Liu X; Hou Y; Li L; Wang L; Chang L; Yang M; Li W; Xia Y
BMC Cancer; 2022 Sep; 22(1):1010. PubMed ID: 36153515
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy plus stereotactic body radiation therapy or whole-brain radiation therapy in brain metastases.
Amin S; Baine M; Lin C
Immunotherapy; 2023 Feb; 15(3):163-174. PubMed ID: 36748364
[No Abstract] [Full Text] [Related]
10. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H
J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291
[TBL] [Abstract][Full Text] [Related]
11. Survival Benefits of Radiotherapy and Surgery in Lung Cancer Brain Metastases with Poor Prognosis Factors.
Liang L; Wang Z; Duan H; He Z; Lu J; Jiang X; Hu H; Li C; Yu C; Zhong S; Cui R; Guo X; Deng M; Chen Y; Du X; Wu S; Chen L; Mou Y
Curr Oncol; 2023 Feb; 30(2):2227-2236. PubMed ID: 36826133
[TBL] [Abstract][Full Text] [Related]
12. Use of radiotherapy in breast cancer patients with brain metastases: a retrospective 11-year single center study.
Gullhaug A; Hjermstad MJ; Yri O; Svestad JG; Aass N; Johansen S
J Med Imaging Radiat Sci; 2021 Jun; 52(2):214-222. PubMed ID: 33549504
[TBL] [Abstract][Full Text] [Related]
13. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
[TBL] [Abstract][Full Text] [Related]
14. Whole-brain radiotherapy plus sequential or simultaneous integrated boost for the treatment of a limited number of brain metastases in non-small cell lung cancer: A single-institution study.
Qing D; Zhao B; Zhou YC; Zhu HL; Ma DY
Cancer Med; 2020 Jan; 9(1):238-246. PubMed ID: 31749325
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of apatinib combined with whole-brain radiation therapy with a simultaneous integrated boost for brain metastases from non-small cell lung cancer: a multicenter retrospective study.
Ma J; Bi J; Tuo X; Pi G; Li Y; Li Y; Zeng F; Gong H; Hu D; Han G
J Thorac Dis; 2022 Feb; 14(2):455-463. PubMed ID: 35280489
[TBL] [Abstract][Full Text] [Related]
16. Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy.
Sehgal K; Gill RR; Widick P; Bindal P; McDonald DC; Shea M; Rangachari D; Costa DB
JAMA Netw Open; 2021 Feb; 4(2):e2037120. PubMed ID: 33570575
[TBL] [Abstract][Full Text] [Related]
17. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
[TBL] [Abstract][Full Text] [Related]
18. Hippocampal avoidance with volumetric modulated arc therapy in melanoma brain metastases - the first Australian experience.
Awad R; Fogarty G; Hong A; Kelly P; Ng D; Santos D; Haydu L
Radiat Oncol; 2013 Mar; 8():62. PubMed ID: 23497418
[TBL] [Abstract][Full Text] [Related]
19. Repeated Stereotactic Radiotherapy for Local Brain Metastases Failure or Distant Brain Recurrent: A Retrospective Study of 184 Patients.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Mazzara C; Cebula H; Noel G; Antoni D
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894315
[TBL] [Abstract][Full Text] [Related]
20. Survival and intracranial control outcomes of whole-brain radiotherapy (WBRT) alone versus WBRT plus a radiotherapy boost in non-small-cell lung cancer with brain metastases: a single-institution retrospective analysis.
Lu F; Hou Y; Xia Y; Li L; Wang L; Cao K; Chen H; Chang L; Li W
Cancer Manag Res; 2019; 11():4255-4272. PubMed ID: 31190992
[No Abstract] [Full Text] [Related]
[Next] [New Search]
